Newborn respiratory distress syndrome is a breathing problem that mainly affects premature babies in the first hours after birth. It happens when the lungs are not making enough surfactant, a substance that helps air sacs stay open. Many people first hear about newborn respiratory distress syndrome when a baby starts breathing fast, grunting, or pulling in at the ribs, which are common early symptoms of newborn respiratory distress syndrome. Newborn respiratory distress syndrome is usually treated in the hospital with oxygen, breathing support, and sometimes surfactant medicine, and symptoms often improve over several days as the lungs mature. The outlook depends on how early a baby was born and how severe the illness is, but with modern newborn care, most babies survive.
How many people live with Newborn respiratory distress syndrome?
Because newborn respiratory distress syndrome is a short-term breathing problem in the first days of life, estimates are usually given as how many babies develop it each year rather than how many people are living with it; worldwide, that is about 1.3 million babies a year, based on roughly 130 million births and the widely used estimate that it affects about 1% of newborns (United Nations, 2024; StatPearls, 2024). In the United States, that works out to about 36,000 babies a year, using about 3.6 million births and the same 1% estimate (CDC, 2024; StatPearls, 2024).
Overview
Newborn respiratory distress syndromeSymptoms
Newborn respiratory distress syndrome causes fast, hard breathing soon after birth. Common signs include grunting, flaring nostrils, chest pulling in with each breath, bluish skin or lips, and trouble getting enough oxygen.
Outlook and prognosis
With prompt treatment, newborn respiratory distress syndrome often improves over hours to days as the lungs mature. Many babies recover fully, especially those born closer to term. Outlook depends on prematurity, infection, and whether other health problems are present.
Causes and risk factors
Newborn respiratory distress syndrome is mainly caused by immature lungs, especially in babies born early. Risk rises with maternal diabetes, cesarean birth before labor, male sex, multiple pregnancy, and rarely inherited surfactant-related gene changes.
Genetic influences
Genetics usually plays a limited role in newborn respiratory distress syndrome, with prematurity being far more important. Rare gene changes affecting surfactant production can increase risk, so genetics matters most in unusual, severe, or recurrent cases.
Diagnosis
Newborn respiratory distress syndrome is diagnosed from a newborn’s breathing problems, exam, and oxygen levels soon after birth. Doctors usually confirm the diagnosis of Newborn respiratory distress syndrome with a chest X-ray, and sometimes blood gas tests.
Treatment and drugs
Treatment for newborn respiratory distress syndrome focuses on helping the lungs work while they mature. Many babies need extra oxygen, breathing support such as CPAP or a ventilator, and some receive surfactant medicine placed directly into the lungs.
Symptoms
Breathing can look like hard work in the first hours after birth, with fast breaths, chest pulling in, or a soft grunting sound. In babies with newborn respiratory distress syndrome, the lungs do not stay open as easily as they should, so getting enough oxygen takes more effort. You might notice small changes at first, but the early symptoms of newborn respiratory distress syndrome often build quickly and need urgent medical care.
Many babies with this condition breathe much faster than usual soon after birth. The breaths may also seem shallow, as if each one is taking extra effort.
A baby may make a low grunting sound, especially when breathing out. This is the body's way of trying to keep the tiny air sacs in the lungs open.
The nostrils may widen with each breath. This often happens when a newborn is working harder to pull air into the lungs.
The skin between the ribs, under the ribs, or at the base of the neck may pull inward during breathing. Day to day, it can feel like every breath is a strain, even while the baby is resting quietly.
How people usually first notice Newborn respiratory distress syndrome?
Newborn respiratory distress syndrome is usually first noticed in the first minutes to hours after birth, when a baby breathes very fast, makes a grunting sound, or seems to work hard to breathe with the chest pulling in under the ribs or at the base of the neck. Many living with this condition also develop flaring nostrils, a bluish tint to the lips or skin from low oxygen, and trouble feeding or staying alert because breathing takes so much effort. The first signs of newborn respiratory distress syndrome are most common in babies born early, because their lungs may not yet make enough surfactant, a slippery substance that helps keep the air sacs open.
Types of Newborn respiratory distress syndrome
Newborn respiratory distress syndrome can look a little different from one baby to another, mostly based on how hard it is for the lungs to stay open after birth. The condition is often described by severity rather than by separate disease subtypes. Symptoms don’t always look the same for everyone. In practice, the early symptoms of newborn respiratory distress syndrome may be mild at first or become more obvious within the first hours of life.
Mild
Babies with mild newborn respiratory distress syndrome may breathe faster than usual and need extra effort to breathe, but they can often keep a reasonable oxygen level with support. You might notice soft grunting, slight flaring of the nostrils, or mild pulling in of the skin between the ribs.
Moderate
In moderate newborn respiratory distress syndrome, breathing trouble is more noticeable and often needs oxygen or breathing support soon after birth. Grunting is usually clearer, chest retractions are stronger, and the baby may look tired during routine care such as feeding or being handled.
Severe
Severe newborn respiratory distress syndrome means the lungs are struggling a great deal to exchange oxygen and keep air sacs open. Babies may have marked chest retractions, very rapid or weakening breathing, bluish skin or lips, and may need urgent intensive care with a breathing machine.
Can I slow down the onset of symptoms?
Yes, sometimes: for newborn respiratory distress syndrome, which is a breathing problem most common in babies born too early, the best-supported ways to lower the chance of symptoms starting right after birth are delaying preterm birth when possible, getting regular pregnancy care, avoiding non-needed early delivery, and keeping health problems such as diabetes well controlled during pregnancy; these steps can reduce risk, but they cannot fully prevent it. If an early birth looks likely, doctors often give steroid shots before delivery to help the baby’s lungs mature faster, and this is a well-established medical step that can lower the risk and severity of symptoms. Even with the best care, some babies will still have this problem, but early planning and treatment can make a real difference.
What genetics can tell you about symptoms
For most babies with newborn respiratory distress syndrome, genetics does not strongly predict the exact symptoms, because the biggest factors are how early the baby is born and how mature the lungs are at birth. Still, rare inherited changes in genes involved in making or handling surfactant, the slippery substance that helps keep the air sacs open, can affect whether breathing problems begin right away, how severe they are, and whether they improve as expected. This matters most when a full-term baby has unusually severe breathing trouble or when symptoms last longer than typical, since in those cases genetic testing may help explain the pattern.
Causes and risk factors
Newborn respiratory distress syndrome usually happens when a baby’s lungs are too immature to make enough surfactant, which helps the tiny air sacs stay open. The biggest risk factor is being born early, especially before 34 weeks of pregnancy. The risk is also higher in babies of mothers with diabetes, in twins or other multiples, and after a cesarean birth before labor starts. Rare inherited gene changes can affect surfactant too, and smoking during pregnancy can raise risk by making preterm birth more likely. Not every baby with the same risk develops the condition, and steroid treatment before a likely preterm birth can lower the chance of newborn respiratory distress syndrome.
What are the most common causes or risk factors?
The most common cause of newborn respiratory distress syndrome is being born too early, before the lungs have made enough of a slippery substance called surfactant, which helps keep the tiny air sacs open. The biggest risk factor is prematurity, and the risk is also higher in babies born by planned cesarean delivery before labor starts, babies of mothers with diabetes, babies from multiple pregnancies such as twins or triplets, and baby boys. Rarely, an inherited gene change that affects surfactant can play a role, but this is much less common than prematurity.
Environmental and biological risk factors
Newborn respiratory distress syndrome happens when a baby's lungs are not ready to keep the tiny air sacs open after birth. The main risk factors for newborn respiratory distress syndrome relate to how mature the lungs are before delivery and what happens around birth. Doctors often group risks into internal (biological) and external (environmental). Knowing these risks can help families and care teams prepare early support.
Babies born early have less time to make enough surfactant, the substance that helps keep the air sacs open. This makes newborn respiratory distress syndrome much more likely, especially before 34 weeks of pregnancy.
Baby boys have a slightly higher risk because lung maturity often develops a bit later. This difference is small, but it is seen often enough to matter.
If the pregnant parent has diabetes, a baby's lungs may mature more slowly even when birth is close to full term. This can raise the chance of newborn respiratory distress syndrome.
Babies born by cesarean section before labor starts may miss some of the hormonal changes that help the lungs prepare for first breaths. This can increase the risk of newborn respiratory distress syndrome, especially when the baby is also early.
Genetic risk factors
For many families, the inherited side of newborn respiratory distress syndrome comes down to how well a baby's lungs make and handle surfactant, the slippery substance that keeps tiny air sacs open after birth. Some risk factors are inherited through our genes. When doctors look for genetic causes of newborn respiratory distress syndrome, they mainly focus on genes that control surfactant, especially if breathing trouble is severe in a full-term baby or runs in the family.
Family history: A close family history of severe breathing problems in newborns can point to an inherited tendency. This is especially important when more than one baby in the family was affected or when a full-term baby became very sick soon after birth.
SFTPB changes: Changes in the SFTPB gene can prevent the lungs from making an important surfactant protein. This rare inherited condition often causes very severe respiratory distress right after birth, even in babies born at term.
ABCA3 changes: Changes in ABCA3 can disrupt how surfactant is packed and moved inside lung cells. Depending on the exact gene change, newborn respiratory distress syndrome can be severe from birth or followed by longer-lasting lung problems.
SFTPC changes: Changes in SFTPC affect another surfactant protein and can make the lungs work less smoothly. Some babies have breathing trouble in the newborn period, while others become ill later in infancy or childhood.
NKX2-1 changes: Changes in NKX2-1 can reduce surfactant production and affect lung development. Some babies with this inherited condition also have thyroid problems or unusual movements, but the pattern can vary a lot.
Male sex: Boys have a higher risk of newborn respiratory distress syndrome than girls. The reason is not fully clear, but lung maturation and surfactant production often happen a little later in male babies.
Lifestyle risk factors
Newborn respiratory distress syndrome is mainly linked to lung immaturity, so parental lifestyle habits do not directly cause it. Still, some modifiable behaviors during pregnancy can increase the chance of premature delivery or interfere with fetal lung development, which is central to how lifestyle affects newborn respiratory distress syndrome. The most relevant lifestyle risk factors are those that raise preterm birth risk or reduce placental oxygen and nutrient delivery.
Smoking during pregnancy can reduce oxygen delivery to the fetus and is linked to a higher risk of preterm birth. Because respiratory distress syndrome is much more common in premature babies, smoking can indirectly increase the chance of this condition.
Alcohol use in pregnancy can disrupt normal fetal growth and raise the risk of pregnancy complications that lead to early delivery. In that way, it can contribute to lifestyle risk factors for newborn respiratory distress syndrome by increasing the likelihood of lung immaturity at birth.
Cocaine, opioids, and other non-prescribed drugs can impair placental blood flow or trigger preterm labor. This can leave the baby's lungs less prepared for breathing after birth and increase the risk of respiratory distress syndrome.
Inadequate nutrition during pregnancy can contribute to poor fetal growth and may worsen overall pregnancy health. When maternal health is affected enough to increase preterm birth risk, the baby's lungs may have less time to mature before delivery.
Risk prevention
Newborn respiratory distress syndrome is most often linked to being born too early, so prevention mainly focuses on lowering the chance of preterm birth and preparing the baby's lungs when early delivery cannot be avoided. This can matter in very practical ways, such as when labor starts weeks ahead of schedule or a cesarean birth is being planned before the due date. Prevention can mean both medical steps, like steroid shots during pregnancy, and lifestyle steps, like avoiding smoking. Some babies will still develop newborn respiratory distress syndrome despite good care, but the risk can often be reduced.
The risk of newborn respiratory distress syndrome is lower when a baby is born closer to full term, because the lungs have more time to mature. Avoiding nonurgent induction or cesarean birth before term can help reduce that risk.
Good prenatal care can help spot problems that raise the chance of early labor, such as infection, high blood pressure, or a short cervix. For people at higher risk, doctors may suggest treatments or closer monitoring to help prolong pregnancy.
If preterm birth looks likely, steroid injections during pregnancy can speed up lung development in the baby. This is one of the most effective answers to how to prevent newborn respiratory distress syndrome in babies expected to arrive early.
Poorly controlled diabetes in pregnancy can delay lung maturity, even when birth is near term. Keeping blood sugar in range with regular prenatal care may help lower the risk of newborn respiratory distress syndrome.
Can you prevent Newborn respiratory distress syndrome?
You cannot always prevent newborn respiratory distress syndrome, because it mainly happens when a baby is born too early and the lungs are not fully ready. Good prenatal care can sometimes lower the risk by helping prevent very early birth when possible, and if an early delivery seems likely, doctors may give the pregnant parent steroid shots before birth to help the baby's lungs mature faster. Even with these steps, some babies still develop it.
Transmission
Newborn respiratory distress syndrome is not an infection, so it cannot be caught from another baby, a parent, or anyone caring for the newborn. It usually happens because a baby's lungs are still immature and do not make enough surfactant, a substance that helps keep the tiny air sacs in the lungs open, which is why it is much more common in babies born early.
Many families ask about how newborn respiratory distress syndrome is inherited, but in most cases it is not passed from parent to child. Instead, the main risk is prematurity, although a few rare inherited conditions can affect surfactant and cause similar breathing problems.
When to test your genes
For newborn respiratory distress syndrome, genetic testing is not part of routine early detection because risk is usually judged by prematurity and the baby’s clinical course. It may be worth discussing if breathing problems are unusually severe, do not improve as expected, or there is a family history suggesting an inherited surfactant disorder.
Diagnosis
Breathing problems in the first hours after birth are often the first clue to newborn respiratory distress syndrome, especially in babies born early. A doctor usually makes the diagnosis by combining what the baby looks like, how much oxygen support is needed, and test results that help rule out other causes of breathing trouble. Doctors usually begin with a physical exam and close monitoring in the nursery or neonatal intensive care unit. Some diagnoses are clear after a single visit, while others take more time.
Doctors look for fast breathing, grunting, flaring of the nostrils, and the chest pulling in with each breath. These signs, along with bluish skin or low oxygen levels, can point to newborn respiratory distress syndrome soon after birth.
The care team considers how early the baby was born and whether there were risk factors such as maternal diabetes or delivery before labor started. This background helps estimate the chance that immature lungs are causing the breathing problem.
A pulse oximeter measures how much oxygen is in the baby's blood, and blood gas tests show how well oxygen and carbon dioxide are being exchanged. These tests help confirm how severe the problem is and guide treatment.
Imaging often shows lungs that look underinflated with a diffuse hazy or ground-glass pattern. These imaging findings support the diagnosis of newborn respiratory distress syndrome and help distinguish it from some other newborn lung problems.
How is Newborn respiratory distress syndrome diagnosed?
Newborn respiratory distress syndrome is usually diagnosed soon after birth based on how the baby is breathing, especially in babies born early, with signs like fast breathing, grunting, flaring nostrils, and the skin pulling in between the ribs. Doctors also check oxygen levels and often do a chest X-ray, which can show that the lungs are not fully opened and are low in air, and they may do blood tests to see how well oxygen is getting into the blood and to rule out infection or other causes of breathing trouble. Genetic testing is not usually part of diagnosing this condition.
Stages of Newborn respiratory distress syndrome
Newborn respiratory distress syndrome does not have defined progression stages. That is because it is usually described by how severe a baby’s breathing trouble is in the first hours to days after birth, rather than by a set step-by-step course that everyone follows. Doctors usually start with a conversation about the pregnancy and birth, then check the baby’s breathing, oxygen level, and how much support is needed. Early symptoms of newborn respiratory distress syndrome, such as fast breathing, grunting, or the skin pulling in between the ribs, are often assessed along with a chest X-ray and sometimes blood gas tests to guide treatment and monitoring.
Outlook and prognosis
The outlook for newborn respiratory distress syndrome is generally good when it is recognized early and treated promptly with supportive care such as oxygen, continuous positive airway pressure, surfactant, and modern neonatal intensive care. Prognosis depends mainly on how premature the baby is, the severity of lung immaturity, and whether complications such as air leaks, infection, intraventricular hemorrhage, or bronchopulmonary dysplasia occur. Most infants who survive the initial illness improve substantially over the first days to weeks as their lungs mature, although very preterm babies may have ongoing breathing problems or longer-term developmental risks related to prematurity. Mortality has fallen greatly in high-resource settings, but the risk of death remains higher in extremely premature infants and in places with limited access to neonatal care. Babies with milder disease often recover fully, while those with the most severe disease may need prolonged respiratory support and close follow-up after discharge. Overall, survival is now high for many affected newborns, but outcomes are closely tied to gestational age, birth weight, and access to experienced neonatal treatment.
Long-term effects
Many babies recover well from newborn respiratory distress syndrome, especially with timely treatment, but some can have lasting effects on breathing and development. The long-term picture is often shaped by how early the baby was born, how severe the lung illness was, and whether other complications of prematurity happened at the same time. Some children later have no obvious problems, while others may need closer follow-up through infancy and early childhood. It’s important to remember that long-term doesn’t always mean progressive.
Some children who had newborn respiratory distress syndrome later have wheezing, shortness of breath, or more coughing with colds and exercise. This is more likely after severe illness, long periods of oxygen support, or extreme prematurity.
A small number of babies go on to develop longer-lasting lung problems, often called bronchopulmonary dysplasia. In these children, the lungs stay more sensitive and may need extra oxygen or breathing support for weeks or months after birth.
Lungs that were injured early in life can be more prone to infections such as bronchiolitis or pneumonia during infancy and early childhood. For many, this can mean more doctor visits, hospital stays, or trouble feeding during illnesses.
Babies recovering from serious lung disease may use more energy just to breathe, which can make weight gain slower at first. Some may tire easily during feeds or need extra nutritional support while they catch up.
How is it to live with Newborn respiratory distress syndrome?
Living with newborn respiratory distress syndrome usually means a baby needs close monitoring in the hospital, often in a neonatal intensive care unit, because breathing can be fast, hard work, and tiring enough to make feeding and sleeping difficult. For parents and other loved ones, daily life can suddenly revolve around incubators, monitors, oxygen, and waiting, which can make bonding feel different at first and bring a lot of fear, exhaustion, and helplessness. The reassuring part is that for many babies, especially with timely treatment, the hardest stretch is early and short, and breathing often improves over days as the lungs mature and recover.
Treatment and drugs
Newborn respiratory distress syndrome is treated by helping a baby breathe while the lungs finish maturing, often in a neonatal intensive care unit. Treatment may include extra oxygen, gentle breathing support through small tubes in the nose or a breathing machine, careful warming, fluids, and close monitoring of blood oxygen and breathing effort. Doctors may also give surfactant, a substance placed into the lungs that helps the tiny air sacs stay open and makes breathing easier. Treatment often looks different for each person, but in newborn respiratory distress syndrome the main goals are to support breathing, prevent complications, and give the lungs time to improve. If the condition is linked with prematurity or infection, babies may also need treatment for those problems, and many improve over days as their lungs get stronger.
Can you cure Newborn respiratory distress syndrome?
There is not a single instant cure for newborn respiratory distress syndrome, but it can often be treated very effectively. Doctors usually give breathing support, extra oxygen, and sometimes surfactant, a natural substance that helps keep a baby's tiny air spaces in the lungs open, while the lungs mature. Many babies improve within a few days and recover fully, though some may need longer care if they were born very early or become very sick.
Non-drug treatment
Breathing support is the main non-drug treatment for newborn respiratory distress syndrome, and it usually starts right after birth in the newborn intensive care unit. Managing this condition often means helping a baby keep the tiny air sacs in the lungs open while the lungs mature. For families, this can look like a baby needing a mask, small nasal prongs, careful warming, and tube or IV feeding for a time.
Continuous positive airway pressure, or CPAP, gently blows air through soft nasal prongs to help keep the lungs open. It is one of the most common early treatments for newborn respiratory distress syndrome and may reduce the need for a breathing tube.
Some babies need added oxygen to keep blood oxygen levels in a safe range while their lungs improve. The care team checks oxygen closely because too little or too much can both be harmful.
If breathing is very hard work or oxygen levels stay low, a ventilator may be needed through a breathing tube. This gives the lungs more support while the baby recovers from severe newborn respiratory distress syndrome.
Close monitoring of breathing, heart rate, blood gases, and oxygen levels helps the team adjust support hour by hour. This is especially important during the early symptoms of newborn respiratory distress syndrome, when changes can happen quickly.
Your genes may have an impact on how drugs work for you
For newborn respiratory distress syndrome, treatment usually centers on breathing support and giving surfactant, a natural slippery substance that helps keep the tiny air sacs in the lungs open, and right now genes do not play a big, routine role in choosing these treatments. Small genetic differences may help explain why some babies respond a little differently or have a higher chance of lung inflammation or side effects, but this is still an area of research and is not yet something doctors commonly use to guide care at the bedside. In everyday practice, the baby’s age at birth, how hard they are working to breathe, and how their oxygen levels and lungs respond over time matter much more than genetic testing.
Pharmacological treatments
Medicines for newborn respiratory distress syndrome are mainly used in the neonatal intensive care unit to help the lungs work better while the baby grows stronger. The main drug treatment is surfactant replacement, which can make breathing easier and lower the risk of complications. Some babies also need other medicines if prematurity leads to related problems like pauses in breathing, or if doctors need to treat possible infection at the same time. For many families, treatment for newborn respiratory distress syndrome includes both medicine and breathing support rather than medicine alone.
Surfactant medicines are the main drug treatment for newborn respiratory distress syndrome because they replace the slippery substance the lungs are missing. Common options include poractant alfa, beractant, and calfactant, which are given directly into the windpipe through a breathing tube. These drugs often work quickly, especially in premature babies with early symptoms of newborn respiratory distress syndrome.
Caffeine citrate may be used in premature babies who also have apnea, meaning short pauses in breathing, along with respiratory distress. It does not replace surfactant, but it can help keep breathing more regular and may reduce the need for a breathing machine. This is most often used as an added treatment in very preterm infants.
Antibiotics such as ampicillin and gentamicin may be started if doctors cannot immediately rule out a serious infection, because infection can look a lot like newborn respiratory distress syndrome in the first hours of life. These medicines do not treat RDS itself, but they are sometimes given until blood tests and cultures are clearer. If infection is ruled out, they are usually stopped.
Inhaled nitric oxide may be used when a baby with severe breathing problems also has high pressure in the lung blood vessels, a problem called pulmonary hypertension. It is not standard treatment for most babies with newborn respiratory distress syndrome, and it is used only in selected cases. Not everyone responds to the same medication in the same way.
Genetic influences
When a baby is struggling to breathe soon after birth, genetics is usually only part of the picture. Most cases of newborn respiratory distress syndrome happen because the lungs are born too early to make enough surfactant, the slippery substance that helps keep the tiny air sacs open. Still, rare inherited changes in genes that help make surfactant or support lung development can raise the risk, and these genetic causes of newborn respiratory distress syndrome are more likely to be considered when a full-term baby is affected or the illness is unusually severe. Family history is one of the strongest clues to a genetic influence. If close relatives had serious breathing problems as newborns, doctors may look more closely for an inherited cause, although most babies with newborn respiratory distress syndrome do not have a single gene condition. When genetics seems important, testing can help explain why the syndrome happened and whether future pregnancies may carry a similar risk.
Is Newborn respiratory distress syndrome genetic?
Genetics usually plays a limited role in newborn respiratory distress syndrome, with prematurity being far more important. Rare gene changes affecting surfactant production can increase risk, so genetics matters most in unusual, severe, or recurrent cases.
Having a genetic risk is not necessarily a diagnosis
Genetic changes are a normal part of human biology and are common in the general population. Most of these changes do not directly affect health and simply reflect natural human diversity. For many genes, having a change linked to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood change in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When a newborn has trouble breathing in the first hours of life, doctors usually choose treatment for newborn respiratory distress syndrome based on how early the baby was born and how much oxygen or breathing support is needed. In most cases, genetics does not yet tell doctors which surfactant medicine to use or the exact dose, because care is still guided mainly by how the baby is doing. Not every difference in response is genetic, but some babies have inherited changes in genes that help make or recycle surfactant, the substance that keeps the lungs’ tiny air sacs open. These babies may have unusually severe or long-lasting symptoms, or may not improve as expected after standard surfactant and breathing support. When that happens, a DNA test may point to a rarer inherited lung problem rather than typical newborn respiratory distress syndrome, and that can change plans for repeat treatments, long-term follow-up, and family counseling. For families wondering about genetic causes of severe newborn respiratory distress syndrome, this means genetic testing is usually used for babies with an unusual course, not as a routine test for every newborn.
Interactions with other conditions
Newborn respiratory distress syndrome can become more complicated when a baby also has another health problem, because low oxygen levels and the extra work of breathing can affect the whole body. Premature babies are especially likely to have related issues such as infection, a heart vessel that stays open after birth, bleeding in the brain, or bowel problems, and each of these can make recovery harder. Doctors call it a “comorbidity” when two conditions occur together, and in newborn respiratory distress syndrome this matters because the signs can overlap, making it harder to tell whether fast breathing or low oxygen is coming from the lungs alone or from another illness as well. For many families, this can mean a baby who needs more careful monitoring, more than one treatment at the same time, or a longer stay in the neonatal unit. Some babies who survive severe newborn respiratory distress syndrome may also have a higher chance of later lung problems, especially if they were very premature or needed prolonged breathing support. If you are reading about early symptoms of newborn respiratory distress syndrome, it helps to know that doctors also look closely for these related conditions so treatment can be coordinated from the start.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Newborn respiratory distress syndrome?
Other newborn problems can look a lot like newborn respiratory distress syndrome, including temporary fast breathing caused by extra fluid in the lungs after birth, a lung infection, breathing trouble after inhaling meconium (a baby’s first stool), or a collapsed lung. Some babies born with heart problems or other lung conditions can also have similar signs, such as fast breathing, grunting, pulling in at the ribs, or low oxygen levels.
History
For much of the last century, one of the hardest moments in newborn care was watching a premature baby struggle to take steady breaths soon after birth. What doctors now call newborn respiratory distress syndrome was described long before its cause was clear, and early reports focused on the pattern parents and care teams could see: fast breathing, chest pulling in with each breath, and babies becoming exhausted in the first hours of life.
In recent decades, awareness has grown as researchers pieced together why this happens. At first, the condition was mainly recognized by what it looked like at the bedside and on early chest X-rays. By the mid-20th century, studies showed that many affected newborns were missing enough of a slippery substance in the lungs, called surfactant, which helps the tiny air sacs stay open. That discovery changed the field, because it explained why newborn respiratory distress syndrome was especially common in babies born too early, before the lungs had fully matured.
From these first observations, treatment steadily improved. Gentle breathing support, better incubator care, and closer monitoring helped more babies survive than in earlier eras. A major step forward came when doctors began giving steroid medicines to some pregnant people at risk of early delivery, which can help speed up fetal lung development before birth. Later, replacement surfactant therapy became available for newborns who needed it, and this dramatically improved outcomes for many living with newborn respiratory distress syndrome.
The history of this condition also includes better recognition that not every baby is affected in the same way. Some have mild breathing trouble that settles with support, while others need intensive care and a ventilator for a time. Today, early symptoms of newborn respiratory distress syndrome are usually recognized quickly in delivery rooms and neonatal units, and modern care has made the condition far more treatable than it once was. Knowing this history helps explain why timing of birth, lung maturity, and fast access to newborn care still matter so much.